Pharmagal Polskasp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2013-04-08
Share capital
10,000.00 PLN
Registered address
Stargardzka 7-9, 54-156 Wrocław, Poland

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 5 of 6 financial statements were filed late (the longest delay 327 days for 2019).

  • 2025not filed
  • 202405/11/2025
  • 202323/08/2024
  • 202229/11/2023
  • 202105/01/2023
  • 202007/09/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue
This companyUSD 2.44mMedianUSD 1.06mAverageUSD 22.41m
Net profit
This companyUSD 205.11kMedianUSD 37.20kAverageUSD 879.46k
Operating costs
This companyUSD 2.16mMedianUSD 921.66kAverageUSD 21.08m
Assets
This companyUSD 812.78kMedianUSD 609.79kAverageUSD 11.85m

Authorized Representatives

Lech Antoni Piotrowski – Attorney-in-fact (sole)
Marian Dubaj – Management Board Member
Michal Dubaj – Management Board Member

Manner of representation

Each member of the management board is authorised independently to represent the company and sign documents on its behalf.

Ownership

OwnerSharesShare valueStake
Michal Dubaj
74$999.4637%
Milan Dubaj
74$999.4637%
Martin Šnirc
26$351.1613%
Žuffa Tomáš
26$351.1613%

Michal Dubaj and Milan Dubaj hold a combined 74% – the ownership structure indicates family control.

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2013-04-08.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$3,152
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$3,088
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$3,098

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

FAQ

Last updated: 2026-04-25